KR20020038713A - 클린다마이신 질 좌약 조성물 - Google Patents
클린다마이신 질 좌약 조성물 Download PDFInfo
- Publication number
- KR20020038713A KR20020038713A KR1020027001576A KR20027001576A KR20020038713A KR 20020038713 A KR20020038713 A KR 20020038713A KR 1020027001576 A KR1020027001576 A KR 1020027001576A KR 20027001576 A KR20027001576 A KR 20027001576A KR 20020038713 A KR20020038713 A KR 20020038713A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- clindamycin
- ester
- salt
- suppository
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
클린다마이신 포스페이트 질 좌약 조성물 | |
좌약 당 함량 | 성분 |
100 mg1 | 클린다마이신 포스페이트 USP (분쇄됨) |
2,375 mg | Witepsol H-32 (경지방 NF) |
(1) 유리 염기로 환산하여 나타냄. 사용된 클린다마이신 포스페이트의 실제량은효능 분석 (예를 들어, USP)을 기초로 계산함. |
Claims (12)
- 경지방 좌약 기제 중에 분산된 항미생물 유효량의 클린다마이신, 그의 제약상 허용되는 염 또는 에스테르를 함유하는, 질내 투여용 클린다마이신 좌약 조성물.
- 제1항에 있어서, 클린다마이신, 그의 염 또는 에스테르를 그의 유리 염기를 기준으로 10 내지 800 mg 함유하는 조성물로, 상기 클린다마이신, 그의 염 또는 에스테르는 상기 조성물 중에 총 조성물의 약 0.1 중량% 내지 약 60 중량%의 양으로 존재하는 것인 조성물.
- 제2항에 있어서, 상기 경지방이 30 ℃ 내지 40 ℃ 범위의 유동점을 갖는 β다형체 형태인 조성물.
- 제3항에 있어서, 클린다마이신, 그의 염 또는 에스테르를 그의 유리 염기를 기준으로 25 내지 300 mg 함유하는 조성물로, 상기 클린다마이신, 그의 염 또는 에스테르는 상기 조성물 중에 총 조성물의 약 0.5 중량% 내지 약 30 중량%의 양으로 존재하는 것인 조성물.
- 제4항에 있어서, 상기 경지방이 37 ℃ 이하의 유동점을 갖는 β다형체 형태인 조성물.
- 제5항에 있어서, 경지방이 트리글리세라이드 에스테르를 50 % 이상 함유하는, 식물성 C12-C18포화 지방산의 글리세라이드 에스테르 혼합물인 조성물.
- 제6항에 있어서, 클린다마이신, 그의 염 또는 에스테르를 그의 유리 염기를 기준으로 50 내지 200 mg 함유하는 조성물로, 상기 클린다마이신, 그의 염 또는 에스테르는 상기 조성물 중에 총 조성물의 약 1.5 중량% 내지 약 10 중량%의 양으로 존재하는 것인 조성물.
- 제7항에 있어서, 클린다마이신이 클린다마이신의 염 또는 에스테르인 조성물.
- 제8항에 있어서, 클린다마이신의 입자 크기가 10 ㎛ 이하인 조성물.
- 제9항에 있어서, 클린다마이신의 염 또는 에스테르를 그의 유리 염기를 기준으로 50 내지 150 mg 함유하는 조성물로, 상기 클린다마이신의 염 또는 에스테르는 상기 조성물 중에 총 조성물의 약 1.5 중량% 내지 약 7.5 중량%의 양으로 존재하는 것인 조성물.
- 제10항에 있어서, 클린다마이신이 클린다마이신 포스페이트인 조성물.
- 제1항에 있어서, 경지방이 하기의 추가 특징을 갖는 NF 등급 경지방인 조성물.오픈-튜브 융점: 31.0 - 33.0 ℃ (α다형체 형태)고화점: 30.0 - 32.5 ℃ (α다형체 형태)히드록실 값: 1 g 당 수산화칼륨 최대 3 mg비누화 값: 1 g 당 수산화칼륨 240 - 250 mg디글리세라이드: 최대 15 중량%모노글리세라이드: 최대 1 중량%
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14756199P | 1999-08-06 | 1999-08-06 | |
US60/147,561 | 1999-08-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020038713A true KR20020038713A (ko) | 2002-05-23 |
KR100670085B1 KR100670085B1 (ko) | 2007-01-17 |
Family
ID=22522061
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020027001576A KR100670085B1 (ko) | 1999-08-06 | 2000-07-20 | 클린다마이신 질 좌약 조성물 |
Country Status (24)
Country | Link |
---|---|
US (2) | US6495157B1 (ko) |
EP (1) | EP1200065B1 (ko) |
JP (1) | JP2003519095A (ko) |
KR (1) | KR100670085B1 (ko) |
CN (1) | CN1160056C (ko) |
AR (1) | AR025045A1 (ko) |
AT (1) | ATE250408T1 (ko) |
AU (1) | AU768907B2 (ko) |
CA (1) | CA2378572A1 (ko) |
DE (1) | DE60005524T2 (ko) |
DK (1) | DK1200065T3 (ko) |
ES (1) | ES2207532T3 (ko) |
HK (1) | HK1047538A1 (ko) |
HN (1) | HN2000000166A (ko) |
MA (1) | MA26749A1 (ko) |
MX (1) | MXPA02001320A (ko) |
NZ (1) | NZ517039A (ko) |
PA (1) | PA8499101A1 (ko) |
PE (1) | PE20010484A1 (ko) |
PT (1) | PT1200065E (ko) |
SI (1) | SI1200065T1 (ko) |
SV (1) | SV2001000138A (ko) |
TW (1) | TWI232111B (ko) |
WO (1) | WO2001010407A1 (ko) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI232111B (en) * | 1999-08-06 | 2005-05-11 | Upjohn Co | Intravaginal clindamycin ovule composition |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
AU2002238063A1 (en) * | 2002-02-05 | 2004-02-25 | Pharmacia And Upjohn Company | Composition and method for rectal delivery of a lincosamide antibacterial drug |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
WO2005009365A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
JP2006528185A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
WO2005009368A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
US8758820B2 (en) | 2003-08-11 | 2014-06-24 | Shionogi Inc. | Robust pellet |
CA2535398C (en) | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
AU2004270170B2 (en) | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
CA2538064C (en) | 2003-09-15 | 2013-12-17 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
EP1667619A4 (en) * | 2003-09-19 | 2007-10-10 | Drugtech Corp | PHARMACEUTICAL FEEDING SYSTEM |
US20060140990A1 (en) * | 2003-09-19 | 2006-06-29 | Drugtech Corporation | Composition for topical treatment of mixed vaginal infections |
US20050214364A1 (en) * | 2004-03-23 | 2005-09-29 | Hutman Herbert W | Products and methods for treating vaginal infections |
US20070065504A1 (en) * | 2004-03-23 | 2007-03-22 | Lin Shun Y | Products and methods for treating vaginal infections |
AU2005269981A1 (en) | 2004-07-02 | 2006-02-09 | Bonck, John A | Tablet for pulsed delivery |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
US20060078616A1 (en) * | 2004-08-30 | 2006-04-13 | Georgewill Dawaye A | Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol |
CA2605341A1 (en) * | 2005-05-09 | 2006-11-16 | Drugtech Corporation | Modified-release pharmaceutical compositions |
CN100446774C (zh) * | 2005-05-31 | 2008-12-31 | 黑龙江龙桂制药有限公司 | 盐酸克林霉素阴道泡腾片及其制备方法 |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
JP2009522362A (ja) * | 2006-01-05 | 2009-06-11 | ドラッグテック コーポレイション | 薬物送達システム |
AU2006332518A1 (en) * | 2006-01-05 | 2007-07-12 | Drugtech Corporation | Composition and method of use thereof |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
DE102009055644A1 (de) * | 2009-11-25 | 2011-06-01 | Nicole Nedela | Dildo-Set |
CN103735491B (zh) * | 2013-12-31 | 2016-01-13 | 哈尔滨欧替药业有限公司 | 克林霉素磷酸酯阴道膨胀栓及其制备方法和检测方法 |
US10751299B2 (en) * | 2018-09-04 | 2020-08-25 | Babak Ghalili | Cannabinoid and menthol compositions and methods |
US10813963B2 (en) | 2018-09-04 | 2020-10-27 | Babak Ghalili | Veterinary cannabinoid and menthol compositions and methods |
WO2021177938A1 (en) * | 2020-03-02 | 2021-09-10 | Babak Ghalili | Veterinary cannabinoid and menthol compositions and methods |
MX2020011523A (es) * | 2020-10-29 | 2022-05-02 | Exeltis Pharma Mexico S A De C V | Composicion farmaceutica adecuada para administracion vaginal en forma de ovulos y uso de la misma. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2812683B2 (ja) * | 1988-07-26 | 1998-10-22 | 富士製薬工業株式会社 | 持続性を有するモルヒネ直腸投与製剤 |
JPH05213752A (ja) * | 1992-02-06 | 1993-08-24 | Fujisawa Asutora Kk | 坐 剤 |
GB9610359D0 (en) * | 1996-05-17 | 1996-07-24 | Edko Trading Representation | Pharmaceutical compositions |
DE19737348C2 (de) * | 1997-08-27 | 2002-07-25 | Dan-Gabriel Vulpescu | Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung |
TWI232111B (en) * | 1999-08-06 | 2005-05-11 | Upjohn Co | Intravaginal clindamycin ovule composition |
-
2000
- 2000-07-17 TW TW089114267A patent/TWI232111B/zh not_active IP Right Cessation
- 2000-07-20 DE DE60005524T patent/DE60005524T2/de not_active Expired - Lifetime
- 2000-07-20 WO PCT/US2000/019533 patent/WO2001010407A1/en active IP Right Grant
- 2000-07-20 JP JP2001514928A patent/JP2003519095A/ja active Pending
- 2000-07-20 EP EP00948739A patent/EP1200065B1/en not_active Expired - Lifetime
- 2000-07-20 CN CNB008102031A patent/CN1160056C/zh not_active Expired - Lifetime
- 2000-07-20 US US09/619,930 patent/US6495157B1/en not_active Expired - Lifetime
- 2000-07-20 PT PT00948739T patent/PT1200065E/pt unknown
- 2000-07-20 MX MXPA02001320A patent/MXPA02001320A/es active IP Right Grant
- 2000-07-20 DK DK00948739T patent/DK1200065T3/da active
- 2000-07-20 AT AT00948739T patent/ATE250408T1/de active
- 2000-07-20 ES ES00948739T patent/ES2207532T3/es not_active Expired - Lifetime
- 2000-07-20 AU AU62198/00A patent/AU768907B2/en not_active Expired
- 2000-07-20 CA CA002378572A patent/CA2378572A1/en not_active Abandoned
- 2000-07-20 KR KR1020027001576A patent/KR100670085B1/ko active IP Right Grant
- 2000-07-20 SI SI200030275T patent/SI1200065T1/xx unknown
- 2000-07-20 NZ NZ517039A patent/NZ517039A/xx not_active IP Right Cessation
- 2000-08-02 HN HN2000000166A patent/HN2000000166A/es unknown
- 2000-08-04 MA MA26034A patent/MA26749A1/fr unknown
- 2000-08-04 PE PE2000000779A patent/PE20010484A1/es not_active IP Right Cessation
- 2000-08-04 AR ARP000104042A patent/AR025045A1/es not_active Application Discontinuation
- 2000-08-04 PA PA20008499101A patent/PA8499101A1/es unknown
- 2000-08-07 SV SV2000000138A patent/SV2001000138A/es active IP Right Grant
-
2002
- 2002-02-05 US US10/072,492 patent/US20020197320A1/en not_active Abandoned
- 2002-11-29 HK HK02108642A patent/HK1047538A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AR025045A1 (es) | 2002-11-06 |
TWI232111B (en) | 2005-05-11 |
KR100670085B1 (ko) | 2007-01-17 |
PA8499101A1 (es) | 2001-12-14 |
MA26749A1 (fr) | 2004-12-20 |
JP2003519095A (ja) | 2003-06-17 |
AU768907B2 (en) | 2004-01-08 |
CN1160056C (zh) | 2004-08-04 |
CN1360495A (zh) | 2002-07-24 |
PT1200065E (pt) | 2004-02-27 |
ATE250408T1 (de) | 2003-10-15 |
PE20010484A1 (es) | 2001-04-20 |
SV2001000138A (es) | 2001-10-24 |
US20020197320A1 (en) | 2002-12-26 |
EP1200065A1 (en) | 2002-05-02 |
SI1200065T1 (en) | 2004-04-30 |
DK1200065T3 (da) | 2004-02-02 |
DE60005524T2 (de) | 2004-08-05 |
NZ517039A (en) | 2003-01-31 |
HN2000000166A (es) | 2001-04-20 |
CA2378572A1 (en) | 2001-02-15 |
HK1047538A1 (en) | 2003-02-28 |
US6495157B1 (en) | 2002-12-17 |
DE60005524D1 (de) | 2003-10-30 |
AU6219800A (en) | 2001-03-05 |
EP1200065B1 (en) | 2003-09-24 |
MXPA02001320A (es) | 2004-09-10 |
WO2001010407A1 (en) | 2001-02-15 |
ES2207532T3 (es) | 2004-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100670085B1 (ko) | 클린다마이신 질 좌약 조성물 | |
DE69627817T2 (de) | Pharmazeutische zubereitung, die fenofibrat und polyglykolisierte glyceride enthält | |
FI89065C (fi) | Foerfarande foer framstaellning av en ny siklosporin kristallform | |
JP5931314B2 (ja) | 半固形製剤中でのオクテニジン二塩酸塩の使用 | |
US5952383A (en) | Pharmaceutical composition for oral delivery | |
KR20090104813A (ko) | 안구건조증의 치료 | |
AU2012388711B2 (en) | Ophthalmic compositions with omega-3 fatty acids | |
HUT71481A (en) | Pharmaceutical compositions for treatment of seborrea and acne containing 2-phenyl-3-aroyl-benzothiophene derivatives and process for their preparation | |
TW200305437A (en) | Ophthalmic composition | |
US20150202306A1 (en) | Ophthalmic compositions with wax esters | |
BE1007158A3 (fr) | Composition pharmaceutique a base d'une imidazolylcarbazolone destinee a l'adminstration rectale. | |
US4812480A (en) | Composition for administration through a body cavity | |
JP2514093B2 (ja) | 軟カプセル剤 | |
DE3904674A1 (de) | Verwendung einer wirkstoffkombination zur behandlung rheumatischer erkrankungen | |
WO2004014338A1 (en) | Composition and method for rectal delivery of a lincosamide antibacterial drug | |
WO1993012783A1 (en) | Oleaginous ointment | |
WO2008007182A2 (en) | Topical pharmaceutical compositions of mupirocin or pharmaceutically acceptable salts or esters thereof | |
RU2116073C1 (ru) | Фармацевтическая мазь без раздражающего воздействия на кожу и способ ее получения | |
CN103830207A (zh) | 一种酒石酸拉索昔芬贴膏剂 | |
De Villiers | Suppository bases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121227 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20131227 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20141230 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151230 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161229 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171228 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181227 Year of fee payment: 13 |